Advertisement
Screener

ANAPTYSBIO, INC. (ANAB) Auditor

ANAPTYSBIO, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-03: Fiscal year end 2025-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location San Diego, California.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location San Diego, California.
  • 2024-03-11: Fiscal year end 2023-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location San Diego, California.
  • 2023-03-01: Fiscal year end 2022-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location San Diego, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-032025-12-31KPMG LLP185San Diego, CaliforniaNo
2025-02-272024-12-31KPMG LLP185San Diego, CaliforniaNo
2024-03-112023-12-31KPMG LLP185San Diego, CaliforniaNo
2023-03-012022-12-31KPMG LLP185San Diego, CaliforniaNo
2022-03-072021-12-31KPMG LLP185San Diego, CaliforniaNo
2021-02-252020-12-31KPMG LLPSan Diego, CaliforniaNo
2020-03-022019-12-31KPMG LLPSan Diego, California
2019-02-282018-12-31KPMG LLPSan Diego, California
2017-03-082016-12-31KPMG LLPSan Diego, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Innoviva, Inc. (INVA)United States$1.493B4.62
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
OMEROS CORP (OMER)United States$1.456B5.50
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74